These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 13525776)
1. Studies on protection against experimental tularemia in mice. II. Immunogenicity of Bacterium tularense filtrates in mice and enhancement by Hemophilus pertussis vaccine. PANNELL L J Infect Dis; 1958; 102(2):167-73. PubMed ID: 13525776 [No Abstract] [Full Text] [Related]
2. The altered reactivity of mice after immunization with Hemophilus pertussis vaccine. KIND LS J Immunol; 1953 Apr; 70(4):411-20. PubMed ID: 13035134 [No Abstract] [Full Text] [Related]
3. Whooping cough; pertussis agglutinogen skin test after immunization with Hemophilus pertussis vaccine. SAUER LW; MARKLEY ED J Am Med Assoc; 1946 Jul; 131():967-9. PubMed ID: 20989980 [No Abstract] [Full Text] [Related]
4. Adrenal function tests in mice sensitized to histamine with Hemophilus pertussis vaccine. KIND LS; GADSDEN RH Proc Soc Exp Biol Med; 1953 Nov; 84(2):373-5. PubMed ID: 13121044 [No Abstract] [Full Text] [Related]
5. Charcoal agar culture medium for preparing Hemophilus pertussis vaccine. POWELL HM; CULBERTSON CG; ENSMINGER PW Public Health Rep (1896); 1951 Mar; 66(11):346-8. PubMed ID: 14816499 [No Abstract] [Full Text] [Related]
6. Studies on protection against experimental tularemia in mice. I. Altered susceptibility of white mice to tularemia following Hemophilus pertussis vaccination. PANNELL L J Infect Dis; 1958; 102(2):162-6. PubMed ID: 13525775 [No Abstract] [Full Text] [Related]
7. The effect of Haemophilus pertussis vaccine on lymphoid tissue in the rat. BOBACCORSI A; WEST GB J Pharm Pharmacol; 1963 Jan; 15():76-7. PubMed ID: 13971943 [No Abstract] [Full Text] [Related]
8. [Action of Haemophilus pertussis vaccine on resistance to anaphylaxis, histamine allergy, serotonin, acetylcholine and infection, in the murine species and the human genus. Experiences in 30 allergic children with pertussis-tetanus-diphtheria triple vaccine]. MATHOV E Sem Med; 1960 Sep; 117():1085-99. PubMed ID: 13768138 [No Abstract] [Full Text] [Related]
9. Histamine shock in mice sensitized with Hemophilus pertussis vaccine. PARFENTJEV IA; GOODLINE MA J Pharmacol Exp Ther; 1948 Apr; 92(4):411-3. PubMed ID: 18911838 [No Abstract] [Full Text] [Related]
10. The influence of the ventral posterior hypothalamus on Bordetella pertussis vaccine-induced eosinophilia. TJABBES T; de WIED Arch Int Pharmacodyn Ther; 1962 Jan; 135():218-22. PubMed ID: 13921428 [No Abstract] [Full Text] [Related]
11. INVESTIGATIONS INTO THE MECHANISM OF PERTUSSIS VACCINE INDUCED HYPERSENSITIVITY. I. EFFECT OF HEMOPHILUS PERTUSSIS VACCINE ON CAPILLARY ENDOTHELIUM IN RATS. LAWLER R; CLAIRMONT JP; KATO L; GOEZSY B Int Arch Allergy Appl Immunol; 1965; 26():373-6. PubMed ID: 14328073 [No Abstract] [Full Text] [Related]
12. [Studies of the reaction of the living body to pertussis vaccine, with special reference to electromyographic experiments with the intercostal muscles. II. Electromyogram of the intercostal muscles by inoculation with Hemophilus pertussis type I and Hemophilus pertussis toxin after Hemophilus pertussis vaccination]. KURODA I Paediatr Jpn; 1961 Jun; 65():643-8. PubMed ID: 13755302 [No Abstract] [Full Text] [Related]
13. [Effects of crude toxin of Hemophilus pertussis and anti-crude toxin sera on infection with Hemophilus pertussis. II. Effects of repeated pretreatments with crude toxin of Hemophilus pertussis and effects of anti-vaccine sera and the anti-crude sera on infection with Hemophilus pertussis]. KOBAYASHI K Paediatr Jpn; 1961; 65():301-8. PubMed ID: 13757277 [No Abstract] [Full Text] [Related]
14. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model. Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393 [TBL] [Abstract][Full Text] [Related]
15. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model. Komatsu E; Yamaguchi F; Eguchi M; Watanabe M Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876 [TBL] [Abstract][Full Text] [Related]
16. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance. Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393 [TBL] [Abstract][Full Text] [Related]
17. Severe active cutaneous hypersensitivity in the rat produced by Hemophilus pertussis vaccine. ROWLEY DA; CHUTKOW J; ATTIG C J Exp Med; 1959 Nov; 110(5):751-69. PubMed ID: 14439721 [TBL] [Abstract][Full Text] [Related]
18. Roads to the development of improved pertussis vaccines paved by immunology. Brummelman J; Wilk MM; Han WG; van Els CA; Mills KH Pathog Dis; 2015 Nov; 73(8):ftv067. PubMed ID: 26347400 [TBL] [Abstract][Full Text] [Related]
19. Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough. Bouchez V; Guiso N Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242280 [TBL] [Abstract][Full Text] [Related]
20. The ability of pertussis vaccine to produce in mice specific immunity of a type not associated with antibody production. EVANS DG; PERKINS FT Br J Exp Pathol; 1954 Aug; 35(4):322-30. PubMed ID: 13190117 [No Abstract] [Full Text] [Related] [Next] [New Search]